Inhaled mRNA therapy for advanced lung cancer or lung metastases
Part of Cancer clinical trials.
This trial tests a new inhaled mRNA therapy that may help your immune system fight cancer. It is for people with advanced lung cancer or cancer that has spread to the lungs when standard treatments have stopped working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have advanced lung cancer (without certain gene changes or after targeted therapy failed) or cancer that has spread to your lungs, and standard treatments are no longer working.
- You have at least one tumor that can be measured on a scan.
- You are able to take care of yourself (ECOG score 0 or 1).
- Your organs (blood, liver, kidneys) are working well enough.
- You are expected to live at least 12 more weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an inhaled dry powder vaccine that uses mRNA to help your immune system target cancer cells in the lungs. It is for people with advanced lung cancer or solid tumors that have spread to the lungs, who have already tried standard treatments.
This trial tests a new type of immunotherapy that is injected directly into a tumor. The treatment uses mRNA (genetic material) wrapped in a fat particle to stimulate your immune system to attack the cancer. It's for people with advanced solid tumors that haven't responded to standard treatments.
This early-stage trial tests a new mRNA-based drug designed to help your immune system fight advanced cancers that haven't responded to standard treatments. The study measures safety, tolerability, and whether it can slow or shrink your tumor.
This Phase 1/2 study tests an mRNA vaccine (mRNA-4359) either alone or combined with an immune checkpoint antibody (immunotherapy). It’s for people with advanced solid tumors to see if it can shrink tumors and how safe it is.
This trial tests a personalized mRNA vaccine made from your tumor's unique mutations. It is given after surgery to try to train your immune system to fight any remaining cancer cells, with the goal of preventing the cancer from coming back.
This trial tests a personalized mRNA vaccine made from your tumor's unique markers (neoantigens) to train your immune system to fight cancer. It is for people with advanced solid tumors who have not had gene therapy and are healthy enough for the vaccine.
Hear when a new Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.